Hjem › Multipelt myelom › Kentucky › Louisville
Kliniske studier for Multipelt myelom i Louisville, KY
12 studier for Multipelt myelom søker deltakere på steder i og rundt Louisville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
RekruttererFase 3
- Research Site, Louisville
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- Norton Cancer Institute, Louisville
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- Norton Cancer Institute, Louisville
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 2
- Norton Cancer Institute, Louisville
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RekruttererFase 3
- Norton Cancer Institute, Louisville
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
RekruttererFase 1/2
- Norton Healthcare, Inc., Louisville
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 2
- Norton Women's and Children's Hospital, Louisville
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RekruttererFase 3
- Research Site, Louisville
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
RekruttererFase 1
- Norton Cancer Institute St. Matthews, Louisville
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
RekruttererFase 1/2
- Norton Cancer Institute, Louisville
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1/2
- Norton Cancer Institute, Louisville
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Baptist Floyd, New Albany · 4 mi unna
Multipelt myelom-studier i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA42 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Edison, NJ22 studier
Andre studier i Louisville
- Ikke-småcellet lungekreft22 studier
- Fedme17 studier
- Overvekt15 studier
- Kreft (alle typer)14 studier
- Hjertesvikt13 studier
- Akut myelogen leukemi12 studier
- Eggstokkreft12 studier
- Brystkreft11 studier
- Plateepitelcancer i hode og hals11 studier
- Lungekreft11 studier
- Melanom10 studier
- Prostatakreft10 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.